7th Circ. Won't Revive IP Suit Over Amylin Drug Promos
The Seventh Circuit on Friday refused to revive Consumer Health Information Corp.'s copyright infringement suit targeting Amylin Pharmaceuticals Inc. over patient education materials CHIC produced for the diabetes drug Byetta, ruling...To view the full article, register now.
Already a subscriber? Click here to view full article